in order to suppress the pituitary-ovarian axis for treatment of endometriosis , the luteinizing hormone-releasing hormone ( lh-rh ) agonist buserelin ( hoechst canada inc. , montreal , quebec , canada ) was administered by continuous subcutaneous ( sc ) infusion using an osmotic minipump system .
C0034390
quebec
C0006823
canada